Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: The impact of albumin conjugation on the cytotoxic properties of cisplatin, oxaliplatin and auranofin in cancer cells
Valentina Vitalia,
Lorenzo Chiaverinib,
Mirko Severia,
Maria Letizia Trincavellib,
Luigi Messori*a,
Lara Massai*a,
Tiziano Marzo*b and
Chiara Giacomellib
aDepartment of Chemistry ‘Ugo Schiff’, University of Florence, Via della Lastruccia 3, 50019 Sesto Fiorentino (FI), Italy. E-mail: luigi.messori@unifi.it; lara.massai@unifi.it
bDepartment of Pharmacy, University of Pisa, Via Bonanno Pisano 6, 56126, Pisa, Italy. E-mail: tiziano.marzo@unipi.it
First published on 5th May 2026
Abstract
Correction for ‘The impact of albumin conjugation on the cytotoxic properties of cisplatin, oxaliplatin and auranofin in cancer cells’ by Valentina Vitali et al., Inorg. Chem. Front., 2026, 13, 106–111, https://doi.org/10.1039/D5QI01487E.
The authors regret that on page 108, column 2, line 10, readers were incorrectly referred to Table 1 in the SI to find the ICP-OES results showing the amount of gold or platinum in each sample. The correct reference should be to Table 1 within the manuscript, shown at the bottom of page 108, column 2.
Furthermore, the binding ratios given for AF, CIS- and OXA-HSA in the sentence beginning “AF exhibited a binding…” on page 108 are incorrect. The correct values are shown in Table 1 within the original manuscript, and the corrected sentence is provided below.
“AF exhibited a binding ratio of approximately 0.462 gold atoms per HSA molecule, while CIS- and OXA-HSA adducts showed higher values with 0.972 and 0.693 platinum atoms per protein, respectively.”
These errors do not substantially affect the interpretation of the work's results.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © the Partner Organisations 2026 |